Antiviral activity of Formyl Peptide Receptor 2 antagonists against influenza viruses - Archive ouverte HAL Access content directly
Journal Articles Antiviral Research Year : 2017

Antiviral activity of Formyl Peptide Receptor 2 antagonists against influenza viruses

(1) , (1) , (1) , (1) , (1) , (1)
1

Abstract

Influenza viruses are one of the most important respiratory pathogens worldwide, causing both epidemic and pandemic infections. The aim of the study was to evaluate the effect of FPR2 antagonists PBP10 and BOC2 on influenza virus replication. We determined that these molecules exhibit antiviral effects against influenza A (H1N1, H3N2, H6N2) and B viruses. FPR2 antagonists used in combination with oseltamivir showed additive antiviral effects. Mechanistically, the antiviral effect of PBP10 and BOC2 is mediated through early inhibition of virus-induced ERK activation. Finally, our preclinical studies showed that FPR2 antagonists protected mice from lethal infections induced by influenza, both in a prophylactic and therapeutic manner. Thus, FPR2 antagonists might be explored for novel treatments against influenza.
Fichier principal
Vignette du fichier
Courtin et al. revised2.pdf (266.95 Ko) Télécharger le fichier
Vignette du fichier
Courtin et al. Figures revised2.pdf (426.9 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01755130 , version 1 (30-03-2018)

Identifiers

Cite

Noemie Courtin, Aurelien Fotso Fotso, Pierre Fautrad, Floriane Mas, Marie-Christine Alessi, et al.. Antiviral activity of Formyl Peptide Receptor 2 antagonists against influenza viruses. Antiviral Research, 2017, 143, pp.252-261. ⟨10.1016/j.antiviral.2017.05.001⟩. ⟨hal-01755130⟩
218 View
396 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More